Evidence map›Paper›PMID 30511185›Full record

ArticleProbiotics and antimicrobial proteins2019

Characterization, the Antioxidant and Antimicrobial Activity of Exopolysaccharide Isolated from Poultry Origin Lactobacilli.

Muhammad Shahid Riaz Rajoka, Hafiza Mahreen Mehwish, Hafiz Fakhar Hayat, Nazim Hussain, Sobia Sarwar, Humaira Aslam, Ahmad Nadeem, Junling Shi

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Relationship BetweenVeterinary sciences · 2026
    Article
  3. Genetic Characterisation of Closely RelatedInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. ESKAPEE Pathogen Biofilm Control on Surfaces with ProbioticAntibiotics (Basel, Switzerland) · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. An In Vivo Study ofBioMed research international · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Muhammad Shahid Riaz RajokaDepartment of Food Science and Engineering, College of Chemistry and Chemical Engineering, Shenzhen University, Shenzhen, Guangdong, People's Republic of China. shahidrajoka@yahoo.com.ORCID http://orcid.org/0000-0003-0137-4584
Hafiza Mahreen MehwishDepartment of Pharmacy, School of Medicine, Key Laboratory of Novel Health Care Product, Engineering Laboratory of Shenzhen Natural Small Molecules Innovative Drugs, Shenzhen University, Shenzhen, Guangdong, People's Republic of China.
Hafiz Fakhar HayatInstitute of Microbiology, University of Agriculture, Faisalabad, Pakistan.
Nazim HussainCenter for Applied Molecular Biology, University of Punjab, Lahore, Pakistan.
Sobia SarwarDepartment of Pharmacy, University of Agriculture, Faisalabad, Pakistan.
Humaira AslamMuhammad Medical College, Mirpur Khas, Pakistan.
Ahmad NadeemNuclear Institute for Agriculture and Biology, Faisalabad, Pakistan.
Junling ShiKey Laboratory for Space Bioscience and Space Biotechnology, School of Life Sciences, Northwestern Polytechnical University, Xi'an, 710072, Shaanxi, People's Republic of China.
Northwestern Polytechnical University · CNUniversity of Agriculture Faisalabad · PKMirpur University of Science and Technology · PKNuclear Institute for Agriculture and Biology · PKShenzhen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The natural antioxidant agent is urgently needed to prevent the negative effects of newly generated free radicals and chronic disorders. Recently, the microbial exopolysaccharide (EPS) is currently used as a potential biopolymer due to its unique biological characteristics. In this study, the biological potential was carried out on the EPSs produced by Lactobacillus reuteri SHA101 (EPS-lr) and Lactobacillus vaginalis SHA110 (EPS-lvg) isolated from gut cecum samples of healthy poultry birds (hen). As results, the EPS-lr and EPS-lvg showed the emulsifying activity of 37.8 ± 1.6% and 27.8 ± 0.5% after the 360 h, respectively. The scanning electron microscopy analysis of EPS-lr and EPS-lvg demonstrated a smooth surface with a compact structure. The both EPSs exhibited strong antibacterial activity against E. coli and Salmonella typhimurium in vitro. In additions, at 4 mg/mL concentration, the EPS-lr and EPS-lvg samples showed potent antioxidant activity regarding hydroxyl radical DPPH (2,2-diphenyl-1-picrylhydrazyl) radical, superoxide anion radical and reducing power at OD

Indexed as

AnimalsAnti-Bacterial AgentsAntioxidantsCecumChickensEscherichia coliLactobacillusPolysaccharides, BacterialSalmonella typhimuriumAnti-Bacterial AgentsAntioxidantsPolysaccharides, BacterialAnticancerAntioxidantExopolysaccharideLactobacillus reuteriLactobacillus vaginalisPoultry birds

Identifiers

PMID30511185
OpenAlexW2903260597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.